Skip to main content
. Author manuscript; available in PMC: 2011 Sep 15.
Published in final edited form as: J Infect Dis. 2010 Sep 15;202(6):894–898. doi: 10.1086/655780

Figure 2.

Figure 2

Informative antibody titers pre- and post- HCV treatment in HIV-coinfected NR, RELAP and SVR subgroups. Anti-core, E1 and NS4 antibodies levels at baseline and post-treatment in individual patients from the NR, RELAP and SVR groups. The thick short solid bar reflects the mean titer in each group for the pre and post-treatment sample. Statistical differences between pre- and post-therapy values were calculated using the nonparametric Wilcoxon signed rank test. The bottom of the figure shows the P value derived from summation of the antibody LU titers for the 3 antigens.